124 related articles for article (PubMed ID: 1629026)
21.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
22. Interactions of 16alpha-[18F]-fluoroestradiol (FES) with sex steroid binding protein (SBP).
Tewson TJ; Mankoff DA; Peterson LM; Woo I; Petra P
Nucl Med Biol; 1999 Nov; 26(8):905-13. PubMed ID: 10708304
[TBL] [Abstract][Full Text] [Related]
23. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.
Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ
J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285
[TBL] [Abstract][Full Text] [Related]
24. The synthesis of 11 beta-methoxy-[16 alpha-123I] iodoestradiol and its interaction with the estrogen receptor in vivo and in vitro.
Zielinski JE; Larner JM; Hoffer PB; Hochberg RB
J Nucl Med; 1989 Feb; 30(2):209-15. PubMed ID: 2738649
[TBL] [Abstract][Full Text] [Related]
25. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA; Welch MJ; Dehdashti F
Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, receptor binding and biodistribution of the gem-21-chloro-21-iodovinylestradiol derivatives.
Ali H; Rousseau J; van Lier JE
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):613-22. PubMed ID: 8240984
[TBL] [Abstract][Full Text] [Related]
27. 16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors.
VanBrocklin HF; Rocque PA; Lee HV; Carlson KE; Katzenellenbogen JA; Welch MJ
Life Sci; 1993; 53(10):811-9. PubMed ID: 8355567
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor.
Seo JW; Chi DY; Dence CS; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 2007 May; 34(4):383-90. PubMed ID: 17499727
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evaluation of a positron emitting progestin ([18F]fluoro-16 alpha-methyl-19-norprogesterone) for imaging progesterone receptor positive tumours with positron emission tomography.
Verhagen A; Luurtsema G; Pesser JW; de Groot TJ; Wouda S; Oosterhuis JW; Vaalburg W
Cancer Lett; 1991 Aug; 59(2):125-32. PubMed ID: 1884369
[TBL] [Abstract][Full Text] [Related]
30. In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study.
Khayum MA; de Vries EF; Glaudemans AW; Dierckx RA; Doorduin J
J Nucl Med; 2014 Mar; 55(3):481-7. PubMed ID: 24481026
[TBL] [Abstract][Full Text] [Related]
31. Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16 alpha-fluoroestradiol (FES).
Mankoff DA; Tewson TJ; Eary JF
Nucl Med Biol; 1997 May; 24(4):341-8. PubMed ID: 9257333
[TBL] [Abstract][Full Text] [Related]
32. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
[TBL] [Abstract][Full Text] [Related]
34. 2- and 4-fluorinated 16 alpha(-)[125I]iodoestradiol derivatives: synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake.
Ali H; Rousseau J; Gantchev TG; van Lier JE
J Med Chem; 1993 Dec; 36(26):4255-63. PubMed ID: 8277508
[TBL] [Abstract][Full Text] [Related]
35. Retardation of 17-oxidation of 16 alpha-[18F]fluoroestradiol-17 beta by substitution of deuterium for hydrogen in the 17 alpha position(6).
Bonasera TA; Jonson SD; Pajeau TS; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 1997 Apr; 24(3):239-49. PubMed ID: 9228658
[TBL] [Abstract][Full Text] [Related]
36. 16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs.
Katzenellenbogen JA; McElvany KD; Senderoff SG; Carlson KE; Landvatter SW; Welch MJ
J Nucl Med; 1982 May; 23(5):411-9. PubMed ID: 7077395
[TBL] [Abstract][Full Text] [Related]
37. Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography.
Ahmed N; Langlois R; Rodrigue S; Bénard F; van Lier JE
Nucl Med Biol; 2007 May; 34(4):459-64. PubMed ID: 17499736
[TBL] [Abstract][Full Text] [Related]
38. 16 Alpha-[125I]iodo-11 beta-methoxy-17 beta-estradiol: a radiochemical probe for estrogen-sensitive tissues.
Zielinski JE; Yabuki H; Pahuja SL; Larner JM; Hochberg RB
Endocrinology; 1986 Jul; 119(1):130-9. PubMed ID: 3720661
[TBL] [Abstract][Full Text] [Related]
39. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Jonson SD; Welch MJ
Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of 7 alpha-[11-(4-[125I]iodophenoxy)undecyl]-17 beta-estradiol: a potential vector for therapy of adrenal and estrogen receptor-positive cancers.
DaSilva JN; van Lier JE
J Steroid Biochem Mol Biol; 1990 Sep; 37(1):77-83. PubMed ID: 2242354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
